JOEL ISAACSON & CO., LLC – Regeneron Pharmaceuticals, Inc. Transaction History
JOEL ISAACSON & CO., LLC portfolio value:
$2.23M
portfolio value
JOEL ISAACSON & CO., LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.06% | -2 shares | 315K | $688.87 | 3.23K |
Q2 2022 | share | Decrease | -0.15% | -5 shares | -432K | $591.13 | 3.24K |
Q1 2022 | share | Decrease | -0.18% | -6 shares | 294K | $698.42 | 3.24K |
Q4 2021 | share | Increase | +0.18% | 6 shares | 90K | $642.51 | 3.25K |
Q3 2021 | share | 0.00% | 0 shares | 151K | $605.18 | 3.24K | |
Q2 2021 | share | Decrease | -0.03% | -1 shares | 277K | $558.54 | 3.24K |
Q1 2021 | share | 0.00% | 0 shares | -33K | $473.14 | 3.24K | |
Q4 2020 | share | 0.00% | 0 shares | -249K | $483.11 | 3.24K | |
Q3 2020 | share | Increase | +0.28% | 9 shares | -201K | $559.78 | 3.24K |
Q2 2020 | share | Increase | +7.50% | 226 shares | 548K | $623.65 | 3.23K |
Q1 2020 | share | Increase | +0.40% | 12 shares | 345K | $488.29 | 3.01K |
Q4 2019 | share | 0.00% | 0 shares | 294K | $375.48 | 3K | |
Q3 2019 | share | Decrease | -0.92% | -28 shares | -116K | $277.4 | 3K |
Q2 2019 | share | Decrease | -0.46% | -14 shares | -301K | $313 | 3.02K |
Q1 2019 | share | Increase | +0.83% | 25 shares | 16K | $410.62 | 3.04K |
Q4 2018 | share | Increase | +0.57% | 17 shares | 21K | $373.5 | 3.01K |
Q3 2018 | share | 0.00% | 0 shares | 177K | $404.04 | 3K | |
Q2 2018 | share | Decrease | -0.40% | -12 shares | -2K | $344.99 | 3K |
Q1 2018 | share | Increase | +0.40% | 12 shares | -91K | $344.36 | 3.01K |
Q4 2017 | share | 0.00% | 0 shares | -213K | $375.96 | 3K | |
Q3 2017 | share | 0.00% | 0 shares | -132K | $447.12 | 3K | |
Q2 2017 | share | 0.00% | 0 shares | 310K | $491.14 | 3K | |
Q1 2017 | share | 0.00% | 0 shares | 62K | $387.51 | 3K | |
Q4 2016 | share | 0.00% | 0 shares | -105K | $367.09 | 3K | |
Q3 2016 | share | 0.00% | 0 shares | 158K | $402.02 | 3K | |
Q2 2016 | share | 0.00% | 0 shares | -33K | $349.23 | 3K | |
Q1 2016 | share | 0.00% | 0 shares | -548K | $360.44 | 3K |